Biochemical and immunotoxicological alterations following repeated gallium arsenide exposure and their recoveries by meso-2,3-dimercaptosuccinic acid and 2,3-dimercaptopropane 1-sulfonate administration in rats

Environmental Toxicology and Pharmacology

Volumn 2, Issue 4, 1996, Pages 315-320

  Flora, Swaran J S ^a   Kumar, Pradeep ^b  

^a Div of Pharmacology and Toxicology   (India)

^b Microbiology Def R and D Estab   (India)

Author keywords

Biochemical variable; Chelation therapy; Gallium arsenide; Immunotoxicity; Multiple exposure; Rat

Indexed keywords

ALKALINE PHOSPHATASE; AMINOLEVULINIC ACID; ARSENIC; GALLIUM ARSENIDE; GLUTATHIONE; PORPHOBILINOGEN SYNTHASE; PROTOPORPHYRIN ZINC; SUCCIMER; UNITHIOL;

ANIMAL MODEL; ANTIBODY PRODUCING CELL; ARTICLE; CHELATION THERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; DRUG TOXICITY; IMMUNE SYSTEM; IMMUNOTOXICITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN; SPLEEN WEIGHT; THYMUS;

EID: 0030596064     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(96)00063-4     Document Type: Article

References (36)

1. Aposhian H.V. 1993, DMSA and DMPS - water soluble antidotes for heavy metal poisoning, Ann. Rev. Pharmacol Toxicol. 23, 193-215.
2. Aposhian, H.V. and M.M. Aposhian, 1990, Meso 2,3-dimercaptosuccinic acid; chemical, pharmacological and lexicological properties of an orally effective metal chelating agent, Ann. Rev. Pharmacol. Toxicol. 30, 279-306.
3. Aposhian, H.V., C.H. Tadlock and T.E. Moon, 1981, Protection of mice against the lethal effects of sodium arsenite; a quantitative comparison of a number of chelating agents, Toxicol. App. Pharmacol. 61, 385-392.
4. Aposhian, H.V., R.M. Maiorino, D. Gonzalez Ramirez, M. Zuniga-Charles, Z. Xu, K.M. Hurlbut, P. Junco-Munoz, R.C. Dart and M.M. Aposhian, 1995, Mobilization of heavy metals by newer therapeutically useful chelating agents, Toxicology 97, 23-38.
5. Berlin, A. and K.H. Schaller, 1974, European standardized method for the determination of δ-aminolevulinic acid dehydratase activity in blood, Z. Klin, Chem. Klin. Biochem. 12, 389-390.
6. Briggs, T.M. and T.W. Ownes, 1980, Industrial Hygiene Characterization of the Photovoltaic Solar Cell Industry, NIOSH Technical Report, DHEW (NIOSH) Publication no. 80-112 (US Department of Health, Education and Welfare, Cincinnati, OH).
7. Burns, L.A., E.E. Sikorski, J.J. Saady and A.E. Munson, 1991, Evidence for arsenic as the primary immunosuppressive component of gallium arsenide, Toxicol. App. Pharmacol. 110, 157-169.
8. Burns., L.A., L.F. Butterworth and A.E. Muson, 1993, Reversal of gallium arsenide induced suppression of the antibody response by a mixed disulfide metabolite of meso-2,3-dimercaptosuccinic acid, J. Pharmacol. Exp. Ther. 264, 695-700.
9. Clegg, J.W. and E.J. King, 1942, Estimation of haemoglobin by the alkaline haematin method, Br. Med. J. 11, 329-330.
10. Cunningham, A.J. and A. Szenberg, 1968, Further improvement in the plaque technique for detecting single antibody forming cell, Immunology 14, 599-608.
11. Davis, J.R., R.H. Abrahams, W.I. Fishbein and E.A. Fabrega, 1969, Urinary δ-aminolevulinic acid (ALA) levels in lead poisoned children, II. Correlation of ALA values with the clinical findings in 250 children with suspected lead ingestion, Arch. Environ. Health 17, 164-171.
12. Ellman, G.L., 1959, Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70-77.
13. Exon, J.H., L.D. Koller, P.A. Talcott, C.A. O'Reilley and G.M. Henningsen, 1986, Immuno toxicity testing and economical multiple assay approach, Fund. App. Toxicol. 7, 387-397.
14. Fiske, C.H. and Y. Subbarow, 1925, The colorimetric determination of phosphates, J. Biol. Chem. 66, 375-379.
15. Flora, S.J.S. and S. Das Gupta, 1992, Effect of single gallium arsenide exposure on some biochemical variables in porphyrin metabolism in rats, J. Appl. Toxicol. 12, 333-334.
16. Flora, S.J.S., S.N. Dube, S.C. Pant and A.S. Sachan, 1994, Effect of multiple gallium arsenide exposure on some biochemical altrerations in rat brain, Indust. Health 32, 239-244.
17. Flora, S.J.S., S.N. Dube, U. Arora, G.M. Kannan, M.K. Shukla and P.R. Malhotra, 1995a, Therapeutic potential of meso 2,3-dimercaptosuccinic acid or 2,3-dimercaptopropane 1-sulfonate in chronic arsenic intoxication in rats, Biometals 8, 11-116.
18. Flora, S.J.S., R. Bhattacharya and R. Vijayaraghavan, 1995b, Combined therapeutic potential of meso 2,3-dimercaptosuccinic acid and calcium disodium edetate on the mobilization and distribution of lead in experimental lead intoxication in rats, Fund. Appl. Toxicol. 25, 233-240.
19. Flora, S.J.S., S. Mathur and R. Mathur, 1995c, Effects of meso 2,3-dimercaptosuccinic acid or 2,3-dimercaptopropane 1-sulfonate on beryllium induced biochemical alterations and metal concentration in male rats, Toxicology 95, 167-175.
20. Goering, P.L., R.R. Maranpot and B.A. Fowler, 1988, Effect of intratracheal gallium arsenide on delta aminolevulinic acid dehydratase in rats; relationship to urinary excretion of aminolevulinic acid, Toxicol. Appl. Pharmacol. 92, 179-193.
21. Grandjean, P., 1979, Occupational lead exposure in Denmark: screening with haematofluorometer, Br. J. Indust. Med. 36, 52-58.
22. Graziano, J.H., 1986, Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning, Med. Toxicol. 1, 155-162.
23. Graziano, J.H., E.S. Siris, N.J. LoIacono, S.J. Silverberg, and L. Turgeon, 1985, 2,3-dimercaptosuccinic acid as an antidote for lead intoxication, Clin. Pharmacol. Ther. 37, 431-438.
24. Hammond, P.B., R.P. Bieliles, C.D. Klaassen, M.O. Amdur and J. Doull (1986) in: Toxicology, The Basic Science of Poisoning, 3rd edn., eds. M. Casarett and J. Doull (MacMillan, New York).
25. 4C dimercaptosuccinic acid in mice, Fund. Appl. Toxicol. 6, 532-540.
26. Mushak, P., K. Dessauer and E.L. Walls, 1977, Flameless atomic absorption (FAA) and gas liquid chromatographic studies in arsenic bioanalysis, Environ. Health Perspect. 19, 5-10.
27. Reitman, S. and S. Frankel, 1957, A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases, Am. J. Clin. Pathol. 28, 56-63.
28. Robinson, A.L., 1983, GaAs readied for high speed microcircuit, Science 219, 275-277.
29. Sikorski, E.E., J.A. McCay, K.L. White, D.G. Page, H.H. Lysy, D.L. Musgrove and A.E. Muson, 1989, Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice, Fund. Appl. Toxicol. 13, 843-858.
30. Sikorski, E.E., L.A. Burns, M.L. Stesh, M.I. Luster and A.E. Musnon, 1991, Splenic cell targets in gallium arsenide induced suppression of the primary antibody response, Toxicol. Appl. Pharmacol. 110, 129-142.
31. Squibb, K.S. and B.A. Fowler, 1983, The toxicity of arsenic and its compounds. In Biological and Environmental Effects of Arsenic, Elsevier, Amsterdam, pp. 233-269.
32. Webb, D.R., I.G. Sipes and D.E. Carter, 1984, In vitro solubility and in vivo toxicity of gallium arsenide, Toxicol. Appl. Pharmacol. 76, 96-104.
33. Webb, D.R., S.E. Wilson and D.E. Carter, 1986, Comparative pulmonary toxicity of gallium arsenide, gallium (III) oxide, or arsenic (III) oxide intratracheally instilled into rats, Toxicol. Appl. Pharmacol. 82, 405-416.
34. Webb, D.R., S.E. Wilson and D.E. Carter, 1987, Pulmonary clearance and toxicity of respirable gallium arsenide particulates intratracheally instilled into rats, Am. Ind. Hyg. Assoc. J. 48, 660-667.
35. Yamamuchi, H., K. Takahashi, M. Mashiko and Y. Yamamura, 1989, Biological monitoring of arsenic exposure of gallium arsenide and inorganic arsenic exposed workers by determination of inorganic arsenic and its metabolites in urine and hair, Am. Ind. Hyg. Assoc. J. 50, 606-612.
36. Zheng, W., R.M. Maiorino, K. Brendel and H.V. Aposhian, 1990, Determination and metabolism of dithiol chelating agents. VII. Biliary excretion of dithiols and their interactions with cadmium and metallothionein, Fund. Appl. Toxicol. 14, 598-607.